Lung cancer: open trials in Croatia

• NCT04613596

  Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.

  Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb · Specijalna Bolnica Medico, Rijeka

  Registry updated 2026-10-30

• NCT06875310

  A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  Trial Treatment · Phase 3 · Mirati Therapeutics Inc.

  Opća bolnica Dubrovnik, Dubrovnik · KBC Zagreb, Grad Zagreb · Klinički bolnički centar Osijek, Osijek · Specijalna Bolnica Medico, Rijeka · KBC Split, Split

  Registry updated 2026-10-27

• 2025-522818-23-00

  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  Trial Treatment · Phase 3 · Zai Lab (US) LLC

  Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb

  Registry updated 2026-10-19

• NCT07393490

  Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.

  Trial Treatment · Osijek University Hospital

  University Hospital Center Osijek, Osijek

  Registry updated 2026-06-26

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error